The present invention discloses pyridoinolobenzo[b,e]diazepine and thiazepine derivatives of Formula 1, ##STR00001##
wherein X is NR.sup.10, S, S(O), or S(O).sub.2. Y is a single bond or no bond. A and B are independently (CH.sub.2).sub.m and (CH.sub.2).sub.n respectively; and the subscripts m and n independently vary from 1 to 4. R.sup.1 to R.sup.9 are various electron donating, electron withdrawing, hydrophilic, or lipophilic groups selected to optimize the physicochemical and biological properties of compounds of Formula I.

The present invention discloses pyridoinolobenzo[b,e]diazepine and thiazepine derivatives of Formula 1,

##STR00001##

wherein X is NR.sup.10, S, S(O), or S(O).sub.2. Y is a single bond or no bond. A and B are independently (CH.sub.2).sub.m and (CH.sub.2).sub.n respectively; and the subscripts m and n independently vary from 1 to 4. R.sup.1 to R.sup.9 are various electron donating, electron withdrawing, hydrophilic, or lipophilic groups selected to optimize the physicochemical and biological properties of compounds of Formula I.

The present invention discloses pyridoinolobenzo[b,e]diazepine and thiazepine derivatives of Formula 1,

##STR00001##

wherein X is NR.sup.10, S, S(O), or S(O).sub.2. Y is a single bond or no bond. A and B are independently (CH.sub.2).sub.m and (CH.sub.2).sub.n respectively; and the subscripts m and n independently vary from 1 to 4. R.sup.1 to R.sup.9 are various electron donating, electron withdrawing, hydrophilic, or lipophilic groups selected to optimize the physicochemical and biological properties of compounds of Formula I.

An organic light emitting device (OLED) is provided. The OLED has an anode, a cathode, and an emission layer, disposed between the anode and the cathode, including a first emitting compound; wherein the first emitting compound is capable of functioning as a blue phosphorescent emitter in the OLED at room temperature; wherein the first emitting compound has PLQY of less than 90% at room temperature; wherein the OLED has an external quantum efficiency of between 8% and 20% at 1 mA/cm.sup.2.

The present application relates to the technical field of organic electroluminescent materials, and provides a nitrogen-containing compound, an organic electroluminescent device including the nitrogen-containing compound, and an electronic apparatus. The nitrogen-containing compound of the present application has a core structure that is indolyl-fused phenothiazine/phenoxazine. The nitrogen-containing compound, when used as a host material of the luminescent layer of an organic electroluminescent device, can significantly improve the luminescence efficiency and service life of the device.

The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of SIK kinase, more in particular SIK1, SIK2 and/or SIK3 and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of SIK-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.

The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of SIK kinase, more in particular SIK1, SIK2 and/or SIK3 and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of SIK-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.

A rare earth complex is represented by general formula (1).

M.sup.3+.Math.(HC).sub.n.Math.(L.sup.1).sub.m.sub.1.Math.(L.sup.2).sub.m.sub.2.Math.(X.sup.L).sub.3-n(1) [In the formula, HC represents a quinolinonato ligand or coumarinato ligand, L.sup.1 represents, for example, a nitrogen-containing ligand, L.sup.2 represents, for example, water, X.sup.L represents, for example, a halide ion, M.sup.3+ represents a trivalent rare earth metal ion, n represents 1, 2 or 3, m.sup.1 represents 0, 1 or 2, and m.sup.2 represents 0 to 3.]

A rare earth complex is represented by general formula (1).

M.sup.3+.Math.(HC).sub.n.Math.(L.sup.1).sub.m.sub.1.Math.(L.sup.2).sub.m.sub.2.Math.(X.sup.L).sub.3-n(1) [In the formula, HC represents a quinolinonato ligand or coumarinato ligand, L.sup.1 represents, for example, a nitrogen-containing ligand, L.sup.2 represents, for example, water, X.sup.L represents, for example, a halide ion, M.sup.3+ represents a trivalent rare earth metal ion, n represents 1, 2 or 3, m.sup.1 represents 0, 1 or 2, and m.sup.2 represents 0 to 3.]

Imidazophenanthridine ligands and metal complexes are provided. The compounds exhibit improved stability through a linking substitution that links a nitrogen bonded carbon of an imidizole ring to a carbon on the adjacent fused aryl ring. The compounds may be used in organic light emitting devices, particularly as emissive dopants, providing devices with improved efficiency, stability, and manufacturing. In particular, the compounds provided herein may be used in blue devices having high efficiency.